Exoskeleton Market by Product (Full Body, Lower Body, Upper Body), Type (Mobile, Stationary), Technology, End User - Global Forecast 2024-2030

Exoskeleton Market by Product (Full Body, Lower Body, Upper Body), Type (Mobile, Stationary), Technology, End User - Global Forecast 2024-2030


The Exoskeleton Market size was estimated at USD 865.78 million in 2023 and expected to reach USD 999.81 million in 2024, at a CAGR 18.20% to reach USD 2,791.19 million by 2030.

Exoskeletons are used to support and assist movement or augment the physical capabilities, disabilities, or limitations resulting from disease or injury that enables patients with lower extremity weakness or partial paralysis to stand and walk on level surfaces. The increasing adoption of human exoskeletons in industrial & military sectors and elevating demand from the healthcare sector for robotic rehabilitation are propelling the market. Additionally, growing awareness and government initiatives for adopting exoskeletons in different industries present various opportunities to capitalize upon. However, the high equipment cost of an exoskeleton robot can pose a challenge to market penetration. Current regulatory issues for securing approvals for medical applications of exoskeletons may impede this progress moderately, given their complex structure. Market players have the opportunity to incorporate technological advancement in materials science, artificial intelligence, and robotics to increase the adoption of exoskeletons in different industries.

Regional Insights

The North American market is responsible for a significant share, including patients' high purchasing power, the growing geriatric population, and the public and private organizations offering grants and funds to develop technologically advanced products. On the other hand, Asia-Pacific is expected to register growth during the forthcoming years owing to a growing patient pool requiring rehabilitation support. Developing & advancing healthcare infrastructure and the availability of government support & funding are driving the development & growth of the exoskeleton market in Asia-Pacific. In Europe, non-manufacturing industries are adopting exoskeleton systems at large for rehabilitation, pick and carry, and other applications. The escalated maritime border tensions between the countries of Russia and Ukraine caused increased military spending worldwide as governments scrambled to upgrade their defensive systems and prepare for potential threats. Additionally, improving economic conditions, coupled with the rising demand for intelligent sensors for quality interaction between human and robotic devices, is expected to boost the exoskeleton market growth in Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Exoskeleton Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Exoskeleton Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Exoskeleton Market, highlighting leading vendors and their innovative profiles. These include ABLE Human Motion S.L., American Bionics, Aselsan AS, ATOUN Inc., B-Temia Inc., Bioness Inc., Bionic Power Inc., BIONIK Inc., Bioservo Technologies AB, Bioventus LLC, Cyberdyne Inc., Dachser Group SE & Co. KG, Dephy Inc., Ekso Bionics Holdings Inc., ExoAtlet, Focal Meditech, Gogoa Mobility Robots, SL, Hilti Corporation, Hocoma AG, Honda Motor Co. Ltd., Honeywell International Inc., Hyundai Motor Company, Innophys Co., Ltd., Ktwo Healthcare Pvt. Ltd., Laevo, Levitate Technologies, Inc., Lockheed Martin Corporation, Marsi Bionics, S.L., Mitsubishi Heavy Industries, Ltd., Myomo, Inc., Noonee Germany GmbH, Northrop Grumman Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Raytheon Technologies Corporation, RB3D, Revision Inc., ReWalk Robotics Ltd., Rex Bionics Ltd., Rostec Corp., Safran S.A., Sarcos Corporation, SpringActive Inc., SRI International Inc., Suit X, Technaid, S.L., The Boeing Company, Toyota Motor Corporation, and Wearable Robotics s.r.l..

Market Segmentation & Coverage

This research report categorizes the Exoskeleton Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Full Body

Lower Body

Upper Body
Type
Mobile

Stationary
Technology
Active

Passive
End User
Hospitals

Manufacturing & Construction

Military & Defense

Rehabilitation Center

Sport & Fitness
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Exoskeleton Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Exoskeleton Market?
3. What are the technology trends and regulatory frameworks in the Exoskeleton Market?
4. What is the market share of the leading vendors in the Exoskeleton Market?
5. Which modes and strategic moves are suitable for entering the Exoskeleton Market?PDF E-mail From Publisher (2-5)Users License


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Exoskeleton Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand from healthcare sector for robotic rehabilitation
5.1.1.2. Increasing adoption of human augmentation equipment in industrial and military sectors
5.1.1.3. Growth in the insurance coverage for medical exoskeletons
5.1.2. Restraints
5.1.2.1. High equipment cost of exoskeleton robots
5.1.3. Opportunities
5.1.3.1. Technological advancement in materials science, artificial intelligence, and robotics
5.1.3.2. Growing awareness and government initiatives for adoption of exoskeletons in different industries
5.1.4. Challenges
5.1.4.1. Regulatory issues for securing approvals for medical applications of exoskeletons
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Exoskeleton Market, by Product
6.1. Introduction
6.2. Full Body
6.3. Lower Body
6.4. Upper Body
7. Exoskeleton Market, by Type
7.1. Introduction
7.2. Mobile
7.3. Stationary
8. Exoskeleton Market, by Technology
8.1. Introduction
8.2. Active
8.3. Passive
9. Exoskeleton Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Manufacturing & Construction
9.4. Military & Defense
9.5. Rehabilitation Center
9.6. Sport & Fitness
10. Americas Exoskeleton Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Exoskeleton Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Exoskeleton Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Ekso Bionics buys Indego exoskeletons from Parker Hannifin.
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Mubea to collaborate on production of carbon fiber exoskeletons.
13.3.2.2. Vanderbilt, 101st Airborne collaborate on development of exoskeleton for soldier use in inaugural Pathfinder Project.
13.3.2.3. Harmonic Bionics and Curexo Enter Strategic Partnership.
13.3.3. New Product Launch & Enhancement
13.3.3.1. Svaya Robotics unveils India’s first homegrown quadruped robot and exoskeleton.
13.3.4. Investment & Funding
13.3.4.1. Smart body suit for neuromuscular disease receives £1.25m (USD 1.56 million) backing.
13.3.4.2. RoboCT brings in USD 15 million for robotic exoskeletons.
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Japanese startup seeks to expand abroad with exoskeleton business.
13.3.5.2. Human in Motion Robotics Awarded $663,000 Contract by Innovative Solutions Canada for Department of National Defense.
13.3.5.3. FDA Clears EksoNR Robotic Exoskeleton for Rehabilitation in Multiple Sclerosis.
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ABLE Human Motion S.L.
14.1.2. American Bionics
14.1.3. Aselsan AS
14.1.4. ATOUN Inc.
14.1.5. B-Temia Inc.
14.1.6. Bioness Inc.
14.1.7. Bionic Power Inc.
14.1.8. BIONIK Inc.
14.1.9. Bioservo Technologies AB
14.1.10. Bioventus LLC
14.1.11. Cyberdyne Inc.
14.1.12. Dachser Group SE & Co. KG
14.1.13. Dephy Inc.
14.1.14. Ekso Bionics Holdings Inc.
14.1.15. ExoAtlet
14.1.16. Focal Meditech
14.1.17. Gogoa Mobility Robots, SL
14.1.18. Hilti Corporation
14.1.19. Hocoma AG
14.1.20. Honda Motor Co. Ltd.
14.1.21. Honeywell International Inc.
14.1.22. Hyundai Motor Company
14.1.23. Innophys Co., Ltd.
14.1.24. Ktwo Healthcare Pvt. Ltd.
14.1.25. Laevo
14.1.26. Levitate Technologies, Inc.
14.1.27. Lockheed Martin Corporation
14.1.28. Marsi Bionics, S.L.
14.1.29. Mitsubishi Heavy Industries, Ltd.
14.1.30. Myomo, Inc.
14.1.31. Noonee Germany GmbH
14.1.32. Northrop Grumman Corporation
14.1.33. Ottobock SE & Co. KGaA
14.1.34. Panasonic Corporation
14.1.35. Parker Hannifin Corporation
14.1.36. Raytheon Technologies Corporation
14.1.37. RB3D
14.1.38. Revision Inc.
14.1.39. ReWalk Robotics Ltd.
14.1.40. Rex Bionics Ltd.
14.1.41. Rostec Corp.
14.1.42. Safran S.A.
14.1.43. Sarcos Corporation
14.1.44. SpringActive Inc.
14.1.45. SRI International Inc.
14.1.46. Suit X
14.1.47. Technaid, S.L.
14.1.48. The Boeing Company
14.1.49. Toyota Motor Corporation
14.1.50. Wearable Robotics s.r.l.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. EXOSKELETON MARKET RESEARCH PROCESS
FIGURE 2. EXOSKELETON MARKET SIZE, 2023 VS 2030
FIGURE 3. EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EXOSKELETON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EXOSKELETON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EXOSKELETON MARKET DYNAMICS
FIGURE 7. EXOSKELETON MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. EXOSKELETON MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EXOSKELETON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. EXOSKELETON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. EXOSKELETON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. EXOSKELETON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings